Tudlasan, Isidra M.
HRN: 27-56-81 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/01/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/01/2025
08/07/2025
IVTT
4.5g
Every 8hrs
CAP-HR
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: